Research & Discoveries

Analysis of 10,478 Cancer Genomes Identifies 330 Potential Drug Targets

A new study reveals that 330 potential driver genes contributing to cancer can be targeted using available and emerging therapeutics.
Analysis of 10,478 Cancer Genomes Identifies 330 Potential Drug Targets
Kateryna Kon/Shutterstock
A.C. Dahnke
|Updated:
0:00

What if you could hone in on the perfect cancer treatment? A tailor-made therapy for your body and the type of cancer you might have?

Researchers focused on precision oncology are one step closer to making that a reality. There are 330 potential driver genes that can cause cancer, 74 of which are newly identified, a new study published in Nature Genetics indicates.
A.C. Dahnke
A.C. Dahnke
Author
A.C. Dahnke is a freelance writer and editor residing in California. She has covered community journalism and health care news for nearly a decade, winning a California Newspaper Publishers Award for her work.